Hear AtLast Holdings, Inc.
Hear AtLast Holdings, Inc.
Your view on HRAL
Overview
What the company does, where it operates, and who runs it.
About Hear AtLast Holdings, Inc.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Peter David Wanner
- Headquarters
- 44 Greystone Crescent, Georgetown, ON, CA
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Peter David Wanner
- Headquarters
- 44 Greystone Crescent, Georgetown, ON, CA
HearAtLast Holdings, Inc. operates hearing clinics in North America. The company offers hearing assessments and hearing instruments.
Its products comprise digital hearing aid instruments and assistive-listening devices, as well as accessories, such as hearing aid wax guards, chargers, cleaners, sound tubes, etc. As of March 31, 2010, HearAtLast Holdings, Inc. had 23 hearing aid clinics within the Wal-Mart structure.
The company was formerly known as 226 Music Group, Inc. and changed its name to HearAtLast Holdings, Inc. in 2007. HearAtLast Holdings, Inc. was founded in 2004 and is headquartered in Georgetown, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Hear AtLast Holdings, Inc., and the rating behind it. HRAL last traded at $0.0004; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Hear AtLast Holdings, Inc.. Starting points for Hear AtLast Holdings, Inc.: beta 0.25 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Hear AtLast Holdings, Inc.. Hear AtLast Holdings, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Hear AtLast Holdings, Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Hear AtLast Holdings, Inc.. Hear AtLast Holdings, Inc. has reported as a listed company since 2009. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Hear AtLast Holdings, Inc. valued side by side against its closest peers. Hear AtLast Holdings, Inc. is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Hear AtLast Holdings, Inc., and how their positions are changing. At a $396 market value, institutional positions materially move Hear AtLast Holdings, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Hear AtLast Holdings, Inc. executives and directors. Shares of Hear AtLast Holdings, Inc. have traded between $0.0003 and $0.0007 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Hear AtLast Holdings, Inc.. Hear AtLast Holdings, Inc. is a $396 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Hear AtLast Holdings, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Hear AtLast Holdings, Inc.. Coverage tracks Hear AtLast Holdings, Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.